The current valuation score of Inhibrx Biosciences Inc is 6.16, ranking 334 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -9.78, which is -101.48% below the recent high of 0.14 and -60.36% above the recent low of -15.68.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.